---
figid: PMC10522922__gr2
pmcid: PMC10522922
image_filename: gr2.jpg
figure_link: /pmc/articles/PMC10522922/figure/fig2/
number: Figure 2
figure_title: ''
caption: SMuRFless CAD Clinical PathwayA novel, evidence-based pathway for investigating
  the potential causes of atherosclerotic CAD in patients with no SMuRFs for improved
  clinical management and secondary prevention. A 2-step, modified Delphi method was
  applied to generate the pathway. Following confirmation of SMuRFless atherosclerotic
  CAD, historic and/or additional investigations (step 4) are required for all patients
  (outlined in red) or if clinically indicated (outlined in purple). Created with
  BioRender.com. Ab = antibody; ACEI = angiotensin-converting enzyme inhibitor; ACS = acute
  coronary syndrome; ANA = antinuclear antibody; ANCA = antineutrophil cytoplasmic
  antibodies; APTT = activated partial thromboplastin clotting time; ARB = angiotensin
  receptor blocker; BP = blood pressure; CAD = coronary artery disease; CCP = cyclic
  citrullinated protein; CM = cardiomyopathy; CCTA = coronary computed tomography
  angiography; CVD = cardiovascular disease; DAPT = dual antiplatelet therapy; HbA1c = glycosylated
  hemoglobin; HDL-C = high-density lipoprotein cholesterol; HOMA = homeostatic model
  assessment for insulin resistance; Hs-CRP = high-sensitivity C-reactive protein;
  IgE = immunoglobulin E; IL = interleukin; LDL-C = low-density lipoprotein cholesterol;
  LV = left ventricle; PAI = plasminogen activator inhibitor; PT = prothrombin time;
  SCAD = spontaneous coronary artery dissection; SMuRF = standard modifiable cardiovascular
  risk factor; TC = total cholesterol; U/S = ultrasound; Vit D = vitamin D.
article_title: Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional
  Modifiable Risk Factors.
citation: Gemma A. Figtree, et al. J Am Coll Cardiol. 2023 Sep 26;82(13):1343-1359.
year: '2023'

doi: 10.1016/j.jacc.2023.06.045
journal_title: Journal of the American College of Cardiology
journal_nlm_ta: J Am Coll Cardiol
publisher_name: Elsevier Biomedical

keywords:
- atherosclerosis
- cardiovascular risk
- clinical pathway
- coronary artery disease
- primary prevention
- secondary prevention

---
